Potential Therapeutic Applications of Synthetic Conotoxin s-cal14.2b, Derived from <i>Californiconus californicus</i>, for Treating Type 2 Diabetes

Potential Therapeutic Applications of Synthetic Conotoxin s-cal14.2b, Derived from <i>Californiconus californicus</i>, for Treating Type 2 Diabetes

The FDA’s approval of peptide drugs such as Ziconotide or Exendin for pain relief and diabetes treatment, respectively, enhanced the interest to explore novel conotoxins from <i>Conus</i> species venom. In general, conotoxins can be used in pathologies where voltage-gated channels, membr...

Full description

Bibliographic Details
Main Authors: Pavel H. Lugo-Fabres, Leslie M. Otero-Sastre, Johanna Bernáldez-Sarabia, Tanya A. Camacho-Villegas, Noemi Sánchez-Campos, Janeth Serrano-Bello, Luis A. Medina, Saé Muñiz-Hernández, Lizbeth de la Cruz, Isabel Arenas, Antonio Barajas-Martínez, David E. Garcia, Linda Nuñez-Garcia, Jorge González-Canudas, Alexei F. Licea-Navarro
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Biomedicines
Subjects:
<i>Californiconus californicus</i>
conotoxins
s-cal14.2b
type 2 diabetes
conodrugs
Online Access:https://www.mdpi.com/2227-9059/9/8/936

Internet

https://www.mdpi.com/2227-9059/9/8/936

Similar Items